Roche says arthritis drug beats top rival in trial
Linkedin

Roche says arthritis drug beats top rival in trial

Zurich : Switzerland | Jun 06, 2012 at 3:09 AM PDT
Source: DAWN
XX XX
Views: Pending
 
RoActemra drug helped to reduce symptoms in rheumatoid arthritis patients better than Abbott Laboratories' top-selling Humira when given as a single treatment, the Swiss drugmaker said on Wednesday. The phase IV trial showed that after 24 weeks of treatment 65 per cent of patients who received RoActemra... FULL ARTICLE AT DAWN
 
  • Clear
  • Share:
  • Share
  • Clear
  • Clear
  • Clear
  • Clear
 
  • Credibility
  • Wait... Flag
 
 
Advertisement
 

More From Allvoices



Use of this site is governed by our Terms of Use Agreement and Privacy Policy.

© Allvoices, Inc. 2008-2014. All rights reserved. Powered by PulsePoint.